Transgenic as edible vaccines for hepatitis B
An important target for vaccines is hepatitis B, a virus causing a chronic liver disease. Serum derived antigens were initially used for immunization against this disease, but due to a variety of safety concerns against this vaccine, recombinant vaccines were developed in yeast. These recombinant vaccines also failed due to high expense and lack of facilities at several places for their production. Therefore, in 1990s and in the year 2000, transgenic tobacco and potato were produced, which expressed hepatitis B surface antigen (HbsAg).


